ChartRow logo
ChartRow
Investing Charts
COO
The Cooper Companies Inc.Stock · HealthcareS&P 500 0.0%
$70.31+$0.08 (+0.11%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

COOThe Cooper Companies Inc. stock price, chart and key statistics

Key stats

Price data

Price
$70.31
Change YTD
-13.32%
Next earnings
Aug 26, 2026
Market cap
13.7B
Enterprise value
15.4B
Shares outstanding
195M
52W low
$58.89
52W high
$89.83
From 52W high
-21.73%
From 52W low
+19.39%
52W range
37%
Beta
0.84

Volume

Rel volume
0.80×
30D volume
2.6M
30D $ vol
180.4M

Fundamentals

Sales (ttm)
4.2B
Sales/share
$21.69
EPS (ttm)
$1.21
FCF (ttm)
569.5M
FCF/share
$2.92
Book value/share
$42.24
Net margin
5.57%
ROE
2.86%
ROA
1.89%
Debt / equity
0.23×
Current ratio
1.27

Growth (CAGR, ttm) · 10Y

Sales
+8.62%
Net income
+1.30%
FCF
+12.41%
Shares
+0.06%

Per-share growth (CAGR, ttm) · 10Y

EPS
+1.35%
Sales/share
+8.55%
FCF/share
+12.33%
Book value/share
+11.58%
Dividend/share
n/a
Price
+4.70%
Total return
+4.72%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
58.2×
Fwd P/E
14.0×
P/S (ttm)
3.2×
P/B (mrq)
1.7×
P/FCF (ttm)
24.1×
EV/EBITDA (fy)
14.6×
EV/Sales (ttm)
3.6×
FCF yield (ttm)
4.15%
Dividend yield (fwd)
0.09%
Dividend/share (fwd)
$0.06
Buyback yield (ttm)
2.61%
Shareholder yield (ttm)
2.61%

Vs own 10Y history

P/E
75th
P/S
2nd
P/B
4th
P/FCF
5th

Bar = where today's multiple sits in COO's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance

1D
+0.11%
1W
-1.95%
1M
+2.15%
3M
+8.25%
YTD
-13.32%
1Y
-4.18%
5Y
-30.37%

Financial statements

Open full COO financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
LLY
Eli Lilly and Company
Pharmaceuticals$1,196+7.05%3.2B
JNJ
Johnson & Johnson
Pharmaceuticals$263+9.30%2.1B
ABBV
AbbVie Inc.
Biopharma$259+10.36%1.9B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$421+3.66%2.6B
MRK
Merck & Co. Inc.
Pharmaceuticals$131+8.70%1.3B
TMO
Thermo Fisher Scientific Inc.
Life Sciences$568+15.45%1.1B
AMGN
Amgen Inc.
Biotech$376+7.00%969.4M
ABT
Abbott Laboratories
Medical Devices$103+13.95%1.3B

The Cooper Companies Inc. (COO) trades at $70.31 with a live price and an interactive chart covering 42+ years of daily price history, plus key valuation metrics. ChartRow also publishes COO's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full COO financial statements →